Skip to main content
. 2017 Oct 2;7:12556. doi: 10.1038/s41598-017-12897-0

Table 1.

Gene ontology enrichment analysis for heat shock treated mice.

comparison regulation genes regulators (1: ChEA, 2: ENCODE) pathways (1: WIKIPathways, 2: Reactome) gene ontologies (biological process) kinases chromatin marks
WT control vs. HS up 570 1: CLOCK 315.2, HSF1 302.42, ESR1 210.21, TCFAP2C 149.06, PPARG 143.32: MYOD1 55.7, MYOG 42.06, HSF1 41.33, EP300 34.79, ZMIZ1 34.45 1: Adipogenesis 23.72, Diurnally Regulated Genes with Circadian Orthologs 9.86, MAPK Signaling Pathway 8.47, Aryl Hydrocarbon Receptor 6.672: Attenuation phase (of HSF1) 26.5, HSF1-dependent transactivation 23.52, Cellular response to heat stress 16.7 response to topologically incorrect protein 39.17, protein refolding 28.18, regulation of p38MAPK cascade 21.76, cellular response to lipid 16.21, regulation of vasculature development 14.86 IRAK4 122.8ILK 83.21IGF1R 56.46ITK 42.54EGFR 41.07 H3K4me1 36.38H3K27me3 27.61H3K27ac 19.79
down 264 1: WT1 86.33, NANOG 81.37, POU5F1 80.23, EP300 66.67, ZFP281 63.942: MAZ 14.9, EP300 12.0, GATA2 10.61, MYOD1 10.53, TCF3 9.86 1: not significant2: Signaling by BMP 13.73, Defective SLC26A2 causes chondrodysplasias 7.29, Extracellular matrix organization 7.19, Defective EXT1 causes exostoses 1, TRPS2 and CHDS 7.18, Oncogene Induced Senescence 7.11 cellular response to lipid 21.06, receptor protein serine/threonine kinase signaling pathway 18.85, BMP signaling pathway 18.08, positive regulation of endothelial cell migration 17.62, regulation of smooth muscle cell migration 15.15 IRAK4 41.39FGFR1 31.01CDK8 19.9BMPR2 10.99KSR2 8.7 H3K27me3 31.73H3K4me3 23.62H3K4me1 17.47
R6/2 control vs. HS up 89 1: CLOCK 69.16, STAT3 45.91, ESR1 40.48, SUZ12 34.81, EGR1 33.552: not significant 1: Corticotropin-releasing hormone 7.05, AGE/RAGE pathway 6.15, Diurnally Regulated Genes with Circadian Orthologs 5.052: HSF1 activation 11.17, Attenuation phase (of HSF1) 11.09, HSF1-dependent transactivation 10.9, Cellular response to heat stress 8.24 cellular response to lipid 15.92, cellular response to hormone stimulus 13.81, negative regulation of calcium ion transport 11.38, response to temperature stimulus 11.12, nitric oxide mediated signal transduction 10.37 IRAK4 20.98AKT1 20.3RAF1 16.98CDK8 9.51ROCK1 8.63 H3K9me3 13.86H3K27me3 10.28H3K4me1 10.24
down 20 1: EP300 19.44, KLF4 7.98, VDR 7.96, GATA2 7.00, DNAJC2 7.002: not significant 1: Striated Muscle Contraction 13.98, Retinol metabolism 8.342: Striated Muscle Contraction 8.19, Signaling by Retinoic Acid 7.79 actin-myosin filament sliding 17.2, negative regulation of cartilage development 13.33, response to leptin 5.41 FGFR1 6.61AKT1 5.56 not significant
Hsf1 −/− control vs. HS up 239 1: ESR1 134.55, CLOCK 108.64, STAT3 91.19, MTF2 80.56, ZNF217 76.022: MYOD1 29.47, ESR1 21.0, STAT3 18.65, TCF12 18.6, RAD21 18.36 1: Adipogenesis 14.47, Oncostatin M Signaling Pathway 9.54, Spinal Cord Injury 9.08, Diurnally Regulated Genes with Circadian Orthologs 8.872: not significant response to oxygen levels 13.14, regulation of heart contraction 12.63, negative regulation of phosphorylation 11.29, negative regulation of cell migration 10.48, Rho protein signal transduction 10.29 IRAK4 70.63KSR1 35.67CDK8 27.78HUNK 23.99IGF1R 19.05 H3K4me1 28.94H3K27me3 24.01H3K9me3 22.37
down 103 1: TCF3 41.25, PPARG 37.09, CLOCK 32.42, POU5F1 28.47, POU3F2 28.472: GATA2 5.63 1: Striated Muscle Contraction 17.28, PPAR signaling pathway 12.95, Adipogenesis genes 7.35, SIDS Susceptibility Pathways 5.782: Striated Muscle Contraction 14.29 muscle filament sliding 24.95, circulatory system process 11.09, positive regulation of osteoclast differentiation 9.22, fat cell differentiation 8.75, lipid storage 8.65 CDK8 24.31ILK 21.09FGFR1 20.89AKT2 12.6IRAK4 8.16 H3K27me3 19.97H3K9me3 13.08H3K9ac 7.42

Upstream regulators were predicted using the ChIP-x Enrichment Analysis (1: ChEA) and ENCODE transcription factor ChIP-seq database 2015 (2: ENCODE).v Chromatin marks were predicted using the ENCODE histone modifications database 2015. Only the top non-redundant significantly enriched terms followed by their combined score are shown. See also Tables S1, S2, S5, S6 and S8.